Bitcoin price today: dips below $112k, near 6-wk low despite Fed cut bets
LeAnn B. Smith, Executive Vice President and Chief Human Resources Officer at McKesson Corp (NYSE:MCK), a prominent healthcare services provider with a market capitalization of $89.5 billion, recently sold a significant portion of her holdings in the company. The stock has shown remarkable strength, gaining nearly 25% year-to-date, according to InvestingPro data. According to a filing with the Securities and Exchange Commission, Smith sold 1,248 shares of McKesson common stock on May 22, 2025, at an average price of $717.30 per share, totaling approximately $895,190. The transaction occurred as the stock trades near its 52-week high of $731, with InvestingPro analysis indicating the stock is fairly valued based on its proprietary Fair Value model.
The sale was part of a pre-established trading plan under Rule 10b5-1(c), which allows insiders to set up a predetermined plan for future stock transactions. This sale follows a series of transactions on May 21, 2025, where Smith acquired 531 shares of common stock through the vesting of Restricted Stock Units (RSUs) and subsequently had 209 shares withheld to cover taxes related to the RSU vesting.
Following these transactions, Smith holds 2,621 shares of McKesson common stock.
In other recent news, McKesson Corporation reported a strong fiscal fourth quarter, surpassing Wall Street’s earnings expectations by 3%. The company announced earnings per share (EPS) that exceeded consensus estimates, with a robust 20% year-over-year growth in EPS. However, revenue for Q3 2025 fell short of expectations, coming in at $90.82 billion against a forecast of $93.48 billion. Despite this revenue miss, McKesson’s management has projected a revenue growth guidance of 11% to 15% for fiscal 2026.
Jefferies analyst Rob Dickerson responded to McKesson’s performance by raising the stock price target to $800, maintaining a Buy rating. This adjustment reflects confidence in McKesson’s forward guidance and long-term EPS growth outlook of 12% to 14%. The company also announced strategic acquisitions, including interests in Prism Vision and pending acquisitions in CORE Ventures, aimed at strengthening its position in healthcare services. Additionally, McKesson plans to separate its Medical (TASE:BLWV) Surgical segment into an independent entity to enhance focus and operational efficiency.
These developments, along with cost optimization efforts resulting in $100 million in savings, underscore McKesson’s strategic advancements and financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.